The Food and Drug Administration (FDA) is launching an effort to streamline the approval process for cheaper alternative ...

The US Food and Drug Administration will take steps to streamline the process to develop generic versions of complex ...

The US Food and Drug Administration (FDA) announced Wednesday that it will relax certain rules for approving low-cost versions of some high-priced medications, in an effort to speed up access to ...

The Trump administration announced a draft framework Wednesday that officials say will speed cheaper versions of biologic ...

Federal regulators are trying to make it easier to develop cheaper alternatives to powerful drugs that many Americans depend ...

The Food and Drug Administration said it will be taking steps to speed up the approval process for developing generic biological drugs, an effort aimed at increasing cheaper competition among ...

The agency will no longer require studies comparing copycat biologics to their branded counterparts, which could help ...

Traditional medications are synthesized through chemical reactions, whereas biologics are derived from and reproduced, at ...

Learn about Rani Therapeutics Holdings, Inc.’s innovative oral biologic drug delivery, current drug pipeline, and investment ...

Clinicians have a new line of weapons in their arsenal to treat recurring nasal polyps. Over the past year several new monoclonal antibody-based biologic drugs have been approved to treat the ...

It's the Trump administration's latest move to rein in high prescription drug costs in the U.S., and could be a blow to ...